Neutrophil Gelatinase Associated Lipocalin Detection Reagent(NGAL) Clinical Comparison In Cardiology

NGAL overview

Gelase (NGAL) is a small protein that is expressed by neutrophils. NGAL is highly expressed in renal tubular epithelial cells and released into the urine and blood within 2 hours after acute kidney injury. Rapid response characteristics, is that a specific degree is high, the influence of other factors, the less sensitive early species can be used as a marker of acute kidney injury, and to predict the diagnosis of sepsis, but may use, high concentrations of ngal in the patient's urine and blood can detect various diseases caused by chronic kidney disease, diagnosis and monitoring of chronic kidney disease, also can use.

NGAL performance index

Main functions of NGAL

NGAL has a lot of power. In addition to being involved in the binding and transport of small hydrophobic molecules in the amyloid family, NGAL is involved in inflammation, embryonic development, immune response, chemical composition, signal transduction, and many types of genesis and development. The tumor.

NGAL can promote the differentiation of renal progenitor cells into early renal lavage epithelial cells, repair N-karmelanin, enhance oxygenase and inhibit apoptosis.

Clinical significance of NGAL

• Early diagnosis and severity evaluation of acute renal injury
• Diagnosis and prognosis of sepsis complicated with nephropathy
• Early warning for diagnosis of chronic and secondary nephropathy.
• Tissue specific evaluation in cancer disease.

Application Department

Nephrology, surgery, oncology, ICU, pediatrics, cardiology, endocrinology, Urology, etc

Clinical Comparison Of NGAL

Company profile

Zhongxiu Science And Technology Co.,Ltd., is a high-tech enterprise engaged in the research and development, production and operation of in vitro diagnostic products. The in vitro diagnostic products developed by the company cover POCT series, microbial series, biochemical series and immune series reagents and supporting instruments.
The company has always adhered to the core concept of "fast and accurate, living up to life", committed to providing society with excellent products and services, and contributing to the cause of human health.

Zhongxiu Science And Technology Co.,Ltd., founded in 2016, is located in Dingluan Industrial Zone, Changyuan City, Henan Province. The company covers an area of about 100 acres and the initial investment is about 200 million yuan. The company has a scientific and complete management system, a purification workshop of national standards, and a fully functional inspection center. On this basis, the company will continue to invest in research and development, accumulate technical strength, update manufacturing equipment, improve production technology, improve inspection technology, improve product quality, and provide customers with safe and effective in vitro diagnostic products.

Zhongxiu Science And Technology Co., Ltd. is a high-tech enterprise engaged in the research and development, production and operation of in vitro diagnostic products. The in vitro diagnostic products developed by the company cover POCT series, immune series, microbial series and other reagents and supporting instruments.

The company has always adhered to the core concept of “fast and accurate, living up to life”, committed to providing society with excellent products and services, and contributing to the cause of human health.